HomeHRTX • NASDAQ
add
Heron Therapeutics Inc
Previous close
$1.12
Day range
$1.11 - $1.17
Year range
$1.00 - $2.68
Market cap
211.78M USD
Avg Volume
2.04M
P/E ratio
52.88
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 38.21M | 16.47% |
Operating expense | 26.92M | 15.32% |
Net income | -17.50M | -260.87% |
Net profit margin | -45.78 | -209.74% |
Earnings per share | -0.04 | -20.33% |
EBITDA | -3.48M | 10.29% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 55.49M | -21.73% |
Total assets | 248.95M | 12.76% |
Total liabilities | 234.06M | -10.24% |
Total equity | 14.88M | — |
Shares outstanding | 183.36M | — |
Price to book | 28.00 | — |
Return on assets | -4.25% | — |
Return on capital | -6.71% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -17.50M | -260.87% |
Cash from operations | 1.33M | -60.52% |
Cash from investing | 11.86M | 198.69% |
Cash from financing | 13.36M | 95,350.00% |
Net change in cash | 26.55M | 261.01% |
Free cash flow | 2.74M | -35.11% |
About
Founded
1983
Headquarters
Website
Employees
122
